An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension

NCT01640964 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Compensated Cirrhosis and Portal Hypertension

Interventions

DRUG: Terlipressin acetate
DRUG: Serelaxin (RLX030)

Sponsor

Novartis Pharmaceuticals